Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour

Documenti analoghi

• The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview
  di: Elise Le Flohic, et al.
  Pubblicazione: (2024)
• Risk of bias tools for medication adherence research: RoBIAS and RoBOAS
  di: Klarissa A. Sinnappah, et al.
  Pubblicazione: (2025)
• Medication adherence—Everybody's problem but nobody's responsibility?
  di: Amy Hai Yan Chan, et al.
  Pubblicazione: (2024)
• Medication adherence for people with acquired communication disorders: A systematic review
  di: Shauna Bell, et al.
  Pubblicazione: (2024)
• A systematic review of medication adherence and mortality in chronic disease: Implications for clinical guidelines and policy
  di: Jessica Hamuy Blanco, et al.
  Pubblicazione: (2025)